23:29 , Jun 11, 2019 |  BC Extra  |  Company News

Management Tracks: Agios’ Biller to retire as CSO; plus Vectura, Molecular Partners, F-star and more

Agios Pharmaceuticals Inc. (NASDAQ:AGIO) said CSO Scott Biller will retire at year end. The cellular metabolism company is searching for a successor. Vectura Group plc (LSE:VEC) said CFO Paul Fry will serve as interim CEO...
19:42 , May 3, 2019 |  BC Extra  |  Company News

Management tracks: Eisai, Nektar, ABPI

In the wake of recent setbacks in Alzheimer's disease, Eisai Co. Ltd. (Tokyo:4523) has charged two VPs with advancing its AD pipeline. The company hired Harald Hampel as VP, global medical affairs and named Michael...
04:19 , Dec 15, 2018 |  BioCentury  |  Product Development

Extending Immunocore’s runway

The $100 million upfront payment from Immunocore Ltd.’s most recent deal with Roche's Genentech Inc. unit gives it enough cash to read out pivotal data from lead program IMCgp100, a catalyst that could help justify...
18:32 , Nov 30, 2018 |  BC Week In Review  |  Company News

Immunocore, Genentech team up to bring soluble TCR therapy into clinic

Despite losing at least five key executives this year, Immunocore Ltd. (Abingdon, U.K.) has teamed up with Genentech Inc. to advance the first soluble TCR-based therapy from their existing deal into clinical testing for solid...
23:15 , Nov 19, 2018 |  BC Extra  |  Company News

Immunocore, Genentech team up to bring soluble TCR therapy into clinic

Despite losing at least five key executives this year, Immunocore Ltd. (Abingdon, U.K.) has teamed up with Genentech Inc. to advance the first soluble TCR-based therapy from their existing deal into clinical testing for solid...
22:34 , Sep 4, 2018 |  BC Extra  |  Financial News

Another C-suite departure at Immunocore

Chief Strategy and Business Officer Kevin Pojasek has left Immunocore Ltd. (Abingdon, U.K.) to join SV Health Investors as venture partner. Pojasek is the fifth C-level executive to leave the TCR company since former CEO...
21:09 , Jul 16, 2018 |  BC Extra  |  Company News

Management tracks: Cerecor, Sangamo

Neurology play Cerecor Inc. (NASDAQ:CERC) said CFO Mariam Morris is stepping down. She is succeeded by Joe Miller, who was VP of finance at Sucampo Pharmaceuticals Inc., which Mallinckrodt plc (NYSE:MNK) acquired. Additionally, Cerecor hired...
20:17 , Aug 16, 2017 |  BC Innovations  |  Emerging Company Profile

Aiming horizontal

SciBac Inc. is using old-school genetics to make therapeutic bacteria that can battle pathogenic organisms and antibiotic-resistant infections. The approach uses horizontal gene transfer to move therapeutic genes from newly discovered species into strains already...
07:00 , Oct 13, 2016 |  BC Innovations  |  Translation in Brief

Dodging CARs

Scientists at NIH's National Cancer Institute have discovered a new way in which acute lymphoblastic leukemia (ALL) cells become resistant to CAR T cell therapy: by changing into myeloid cells. The results highlight the remarkable...
07:00 , Oct 12, 2016 |  BC Extra  |  Company News

Management tracks

T cell receptor (TCR) therapy company Immunocore Ltd. (Abingdon, U.K.) hired Paul Fry as CFO. He was director of global finance operations at Vodafone Group plc (NASDAQ:VOD). Global Blood Therapeutics Inc. (NASDAQ:GBT) hired Tricia Suvari...